Skip to main content

and
  1. Article

    Open Access

    A review on the advances and challenges of immunotherapy for head and neck cancer

    Head and neck cancer (HNC), which includes lip and oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx malignancies, is one of the most common cancers worldwide. Due to the interaction of tumor cells...

    Gang Cheng, Hui Dong, Chen Yang, Yang Liu, Yi Wu, Lifen Zhu in Cancer Cell International (2021)

  2. Article

    Open Access

    CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma

    Immunotherapy with CD19-targeting bispecific T-cell engagers (CD19BiTEs) has demonstrated highly effective killing of cancer cells in patients with precursor acute lymphoblastic leukemia and non-Hodgkin’s lymp...

    Wen Lei, Qian Ye, Yuanyuan Hao, Jie Chen, Yu Huang, Liu Yang in Blood Cancer Journal (2022)

  3. Article

    Open Access

    Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages

    Squamous cell carcinomas are the most common head and neck malignancies. Significant progress has been made in standard therapeutic methods combining surgery, radiation, and chemotherapy. Nevertheless, the 5-y...

    Hui Dong, Mengli Li, Chen Yang, Wei Wei, **anglei He in Cancer Cell International (2023)

  4. No Access

    Article

    Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin’s suppression of oral cancer

    This investigation seeks to explore the mechanism of quercetin in oral cancer by incorporating network pharmacology analysis and molecular docking.

    Hui Dong, Mengli Li, Hong Chen, Linqing Tian in Journal of Cancer Research and Clinical On… (2023)